View Clinical Trial (Medical Research Study)
Efficacy and Safety of a Single Dose of ACZ885 in Hospitalized Patients With Acute Gout - NCT00663169-02115(Clinical Trial 216611)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Boston |
|
State:
|
|
MA |
| Zip Code: |
|
02115 |
| Conditions: |
|
Arthritis, Gouty |
| Purpose: |
|
This is an exploratory proof-of-concept study to evaluate the safety and efficacy of ACZ885
for inflammation and pain associated with acute gouty arthritis.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- score over 50 on the 0-100 VAS pain scale
- acute, confirmed gout flare for no longer than 3 days
Exclusion Criteria:
- Treatment with biological (anti-TNF) within the past 3 months
- Anti-inflammatory medication for the treatment of acute gout within the previous 24
hours
- Pregnant or breastfeeding women
- Major surgery with high infection risk
- History of severe allergy to food or drugs
- History or risk of tuberculosis
- Active infection
Other protocol-defined inclusion/exclusion criteria may apply |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|